Wen-Hsiang Chen, Ph.D.
University of Houston
H-index: 20
North America-United States
Top articles of Wen-Hsiang Chen, Ph.D.
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccine | Frontiers in Drug Delivery | William R Lykins Jeroen Pollet Jessica A White Brian Keegan Leroy Versteeg | 2024/2/7 |
Biophysical and biochemical characterization of a recombinant Lyme disease vaccine antigen, CspZ-YA | International Journal of Biological Macromolecules | Yi-Lin Chen Jungsoon Lee Zhuyun Liu Ulrich Strych Maria Elena Bottazzi | 2024/2/1 |
From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access | Peter J Hotez Rakesh Adhikari Wen-Hsiang Chen Yi-Lin Chen Portia Gillespie | 2023/12/31 | |
A Recombinant Protein XBB. 1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2 | Vaccines | Syamala Rani Thimmiraju Rakesh Adhikari Maria Jose Villar Jungsoon Lee Zhuyun Liu | 2023/10/1 |
CspZ FH-binding sites as epitopes promote antibody-mediated Lyme borreliae clearance | Infection and Immunity | Yi-Lin Chen Ashley L Marcinkiewicz Tristan A Nowak Rakhi Tyagi Kundu Zhuyun Liu | 2022/7/21 |
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern | Vaccine | Jeroen Pollet Ulrich Strych Wen-Hsiang Chen Leroy Versteeg Brian Keegan | 2022/6/9 |
Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate | Protein Expression and Purification | Wen-Hsiang Chen Jeroen Pollet Ulrich Strych Jungsoon Lee Zhuyun Liu | 2022/2/1 |
A novel multi-epitope recombinant protein elicits an antigen-specific CD8+ T cells response in Trypanosoma cruzi-infected mice | Vaccine | Cristina González-López Wen-Hsiang Chen Andrea Alfaro-Chacón Liliana E Villanueva-Lizama Miguel Rosado-Vallado | 2022/10/26 |
Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights | Wen-Hsiang Chen Ulrich Strych Maria Elena Bottazzi Yi-Pin Lin | 2022/10/3 | |
Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate | Biochimica et Biophysica Acta (BBA)-General Subjects | Wen-Hsiang Chen Junfei Wei Rakhi Tyagi Kundu Rakesh Adhikari Zhuyun Liu | 2021/6/1 |
Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain–based vaccine candidate, RBD219-N1C1 | Applied microbiology and biotechnology | Jungsoon Lee Zhuyun Liu Wen-Hsiang Chen Junfei Wei Rakhi Kundu | 2021/5 |
Recombinant protein vaccines, a proven approach against coronavirus pandemics | Jeroen Pollet Wen-Hsiang Chen Ulrich Strych | 2021/3/1 | |
A scalable and reproducible manufacturing process for Phlebotomus papatasi salivary protein PpSP15, a vaccine candidate for leishmaniasis | Protein Expression and Purification | Zhuyun Liu Rakhi Kundu Surafel Damena Amadeo B Biter Mun Peak Nyon | 2021/1/1 |
SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice | Human vaccines & immunotherapeutics | Jeroen Pollet Wen-Hsiang Chen Leroy Versteeg Brian Keegan Bin Zhan | 2021/8/3 |
A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates | Science immunology | Maria Pino Talha Abid Susan Pereira Ribeiro Venkata Viswanadh Edara Katharine Floyd | 2021/7/15 |
Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19 | Wen-Hsiang Chen Peter J Hotez Maria Elena Bottazzi | 2020/6/2 | |
The SARS-CoV-2 vaccine pipeline: an overview | Wen-Hsiang Chen Ulrich Strych Peter J Hotez Maria Elena Bottazzi | 2020/6 | |
Process characterization and biophysical analysis for a yeast-expressed Phlebotomus papatasi salivary protein (PpSP15) as a Leishmania vaccine candidate | Journal of pharmaceutical sciences | Wen-Hsiang Chen Mun Peak Nyon Mohan V Poongavanam Zhuyun Liu Amadeo B Biter | 2020/5/1 |
The factor H-binding site of CspZ as a protective target against multistrain, tick-transmitted Lyme disease | Infection and immunity | Ashley L Marcinkiewicz Ilva Lieknina Xiuli Yang Patricia L Lederman Thomas M Hart | 2020/4/20 |
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with alum induces protective immunity and reduces immune enhancement | Vaccine | Wen-Hsiang Chen Xinrong Tao Anurodh Shankar Agrawal Abdullah Algaissi Bi-Hung Peng | 2020/11/3 |
